Novartis’ and Bayer’s patent battles in India reflect the increasing legal nature of the globalising pharma industry, Mylan Inc CEO Heather Bresch tells Forbes India
The risk associated with doing business in India has accentuated the need to diversify one’s portfolio. And what better way to do it than to invest in the world’s biggest free market?
RS Sharma talks to Forbes India about his tenure as the director general and mission director of the UIDAI and his vision as the new chief secretary of Jharkhand
In response to our story ‘The Rise and Fall of Educomp’ Shantanu Prakash clarified some controversial aspects of the story
R Thyagarajan’s Shriram Transport Finance has kept investors and shareholders happy, several times over. He spells out the small secrets of his huge success
Companies should strive for the right balance between individuals and groups
An eye-witness account of the twin explosions and thoughts thereafter
Roger Martin, dean of Rotman School of Management, tells Forbes India that logic, not data, should be used to formulate strategy
More young people are dying of lifestyle diseases, accidents and violence, rather than infections
The business idea on your drawing board can turn into a prototype in 54 hours